TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
TREACE MEDICAL CONCEPTS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.88+0.01 (+0.26%)
Close on Oct 19, 2026
- Market cap
- $252.39M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
49.0%
32M of 65M shares
Institutional holders
117
31 new, 30 sold out
Net institutional buying
-4M
In Q2 2026
Insider trades, 12 months
14 buys · 0 sales
Net bought $1.45M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 6,364,000 | 9.79% | 13G (passive) amendment | Jun 30, 2026 |
| Steven Boyd | 6,364,000 | 9.85% | 13G (passive) amendment | Mar 31, 2026 |
| Neil Gagnon | 6,142,107 | 9.60% | 13G (passive) amendment | Dec 31, 2025 |
| Bank Of America Corp /De/ | 3,533,774 | 5.50% | 13G (passive) | Mar 31, 2026 |
| John T. Treace | 12,530,959 | 19.20% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TMCI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 6,364,000 | 9.79% | $25.33M | – | 0.31% |
| Bank Of America Corp /De/ | 3,305,100 | 5.08% | $13.15M | +90,807 | 0.00% |
| Gagnon Securities LLC | 3,029,543 | 4.66% | $12.06M | −2,172,343 | 2.32% |
| Vanguard Capital Management LLC | 2,028,479 | 3.12% | $8.07M | +566,972 | 0.00% |
| Gagnon Advisors, LLC | 1,534,034 | 2.36% | $6.11M | New | 3.88% |
| Aqr Capital Management LLC | 1,497,673 | 2.30% | $5.96M | +435,833 | 0.00% |
| BlackRock, Inc. | 1,380,021 | 2.12% | $5.49M | −1,960,002 | 0.00% |
| Marshall Wace, Llp | 1,328,592 | 2.04% | $5.29M | +1,063,659 | 0.00% |
| CIBC Bancorp USA Inc. | 1,216,044 | 1.87% | $4.84M | −2,309 | 0.01% |
| Acadian Asset Management LLC | 928,177 | 1.43% | $3.69K | −13,116 | 0.00% |
| Millennium Management LLC | 738,628 | 1.14% | $2.94M | −409,487 | 0.00% |
| Weber Capital Management LLC /Adv | 589,617 | 0.91% | $2.35M | – | 2.00% |
| D. E. Shaw & Co., Inc. | 583,277 | 0.90% | $2.32M | −257,992 | 0.00% |
| Geode Capital Management, LLC | 573,796 | 0.88% | $2.28M | −437,047 | 0.00% |
| Citadel Advisors LLC | 516,994 | 0.79% | $2.06M | −308,581 | 0.00% |
| Goldman Sachs Group Inc | 492,116 | 0.76% | $1.96M | +104,431 | 0.00% |
| Stifel Financial Corp | 435,009 | 0.67% | $1.73M | +258,917 | 0.00% |
| UBS Group AG | 366,445 | 0.56% | $1.46M | −176,460 | 0.00% |
| Jacobs Levy Equity Management, Inc | 363,729 | 0.56% | $1.45M | +99,995 | 0.01% |
| Raymond James Financial Inc | 331,110 | 0.51% | $1.32M | −26,446 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 117 | 32M | 49.0% | 31 / 38 | 32 / 30 | 5M | 10M |
| Q1 2026 | 118 | 36M | 55.3% | 32 / 34 | 29 / 25 | 11M | 7M |
| Q4 2025 | 115 | 36M | 55.1% | 31 / 30 | 35 / 35 | 8M | 12M |
| Q3 2025 | 119 | 40M | 62.2% | 15 / 44 | 34 / 21 | 5M | 3M |
| Q2 2025 | 125 | 38M | 59.1% | 19 / 48 | 41 / 30 | 4M | 4M |
| Q1 2025 | 138 | 38M | 58.4% | 30 / 41 | 45 / 26 | 5M | 4M |
| Q4 2024 | 135 | 37M | 57.6% | 25 / 42 | 47 / 23 | 3M | 7M |
| Q3 2024 | 134 | 41M | 63.0% | 29 / 35 | 50 / 21 | 12M | 7M |
| Q2 2024 | 128 | 40M | 61.7% | 38 / 55 | 25 / 41 | 12M | 20M |
| Q1 2024 | 132 | 48M | 74.2% | 19 / 48 | 47 / 14 | 9M | 6M |
| Q4 2023 | 127 | 45M | 68.4% | 32 / 47 | 37 / 28 | 18M | 13M |
| Q3 2023 | 123 | 39M | 60.3% | 24 / 63 | 30 / 38 | 8M | 10M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TMCI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,447,595 | 2.23% | $5.76M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 545,595 | 0.84% | $2.17M | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 249,411 | 0.38% | $862.96K | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 229,912 | 0.35% | $795.50K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 170,911 | 0.26% | $591.35K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 165,650 | 0.25% | $659.29K | 0.04% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 150,606 | 0.23% | $521.10K | 0.00% | May 31, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 102,412 | 0.16% | $407.60K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 87,200 | 0.13% | $301.71K | 0.00% | May 31, 2026 |
| iShares Core S&P Total U.S. Stock Market ETF | 72,379 | 0.11% | $288.07K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 72,135 | 0.11% | $249.59K | 0.00% | May 31, 2026 |
| Clearwater Select Equity Fund | 53,238 | 0.08% | $211.89K | 0.04% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 50,000 | 0.08% | $199.00K | 0.13% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 46,975 | 0.07% | $162.53K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 45,333 | 0.07% | $156.85K | 0.01% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John T. Treace | Chief Executive Officer, Director, 10% owner | 12,728,512 | 19.57% | Aug 24, 2026 |
| Mark Hair | Chief Financial Officer | 916,100 | 1.41% | Aug 12, 2026 |
| Sean F. Scanlan | Chief Innovation Officer | 679,863 | 1.05% | Aug 12, 2026 |
| Scot Michael Elder | Chief Legl & Comp Off, CorpSec | 778,683 | 1.20% | Aug 12, 2026 |
| Gaetano Guglielmino | Chief Commercial Officer | 490,901 | 0.75% | Jan 23, 2026 |
| Aaron Berutti | SVP, Sales | 205,092 | 0.32% | Aug 12, 2025 |
| Deepti Jain | Director | 100,243 | 0.15% | May 19, 2026 |
| Lawrence W. Hamilton | Director | 74,056 | 0.11% | May 19, 2026 |
| John K. Bakewell | Director | 546,356 | 0.84% | May 19, 2026 |
| Lance A. Berry | Director | 74,593 | 0.11% | May 19, 2026 |
| Betsy Hanna | Director | 75,243 | 0.12% | May 19, 2026 |
| Jane E. Kiernan | Director | 93,949 | 0.14% | May 19, 2026 |
| Richard W. Mott | Director | 1,498,111 | 2.30% | May 21, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John T. Treace Chief Executive Officer, Director, 10% owner | Aug 24, 2026 | Buy | +11,000 | $4.34 | $47.74K | 7,404,383 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Aug 21, 2026 | Buy | +5,000 | $4.35 | $21.75K | 7,393,383 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Aug 20, 2026 | Buy | +39,944 | $4.44 | $177.35K | 7,388,383 |
| Sean F. Scanlan Chief Innovation Officer | Aug 9, 2026 | Tax withholding | −9,814 | – | – | 679,863 |
| Mark Hair Chief Financial Officer | Aug 9, 2026 | Tax withholding | −37,102 | – | – | 914,900 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Aug 9, 2026 | Tax withholding | −16,253 | – | – | 778,683 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 11, 2026 | Buy | +9,891 | $4.04 | $39.96K | 7,348,439 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 11, 2026 | Buy | +22,887 | $4.04 | $92.46K | 7,376,150 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 10, 2026 | Buy | +14,715 | $4.02 | $59.15K | 7,338,548 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 10, 2026 | Buy | +29,430 | $4.02 | $118.31K | 7,353,263 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jun 1, 2026 | Buy | +50,000 | $3.56 | $178.00K | 7,323,833 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 28, 2026 | Buy | +61,202 | $3.02 | $184.83K | 7,273,833 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 27, 2026 | Buy | +49,810 | $2.87 | $142.95K | 7,212,631 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 26, 2026 | Buy | +4,508 | $2.79 | $12.58K | 7,162,821 |
| Betsy Hanna Director | May 19, 2026 | Award | +30,000 | – | – | 75,243 |
| Jane E. Kiernan Director | May 19, 2026 | Award | +30,000 | – | – | 93,949 |
| Lawrence W. Hamilton Director | May 19, 2026 | Award | +30,000 | – | – | 74,056 |
| John K. Bakewell Director | May 19, 2026 | Award | +30,000 | – | – | 204,056 |
| Deepti Jain Director | May 19, 2026 | Award | +30,000 | – | – | 100,243 |
| Lance A. Berry Director | May 19, 2026 | Award | +30,000 | – | – | 74,593 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 14, 2026 | Buy | +61,750 | $2.62 | $161.79K | 7,158,313 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 13, 2026 | Buy | +49,013 | $2.46 | $120.57K | 7,096,563 |
| John T. Treace Chief Executive Officer, Director, 10% owner | May 12, 2026 | Buy | +43,000 | $2.17 | $93.31K | 7,047,550 |
| Mark Hair Chief Financial Officer | Apr 17, 2026 | Tax withholding | −11,547 | – | – | 952,002 |
| Mark Hair Chief Financial Officer | Apr 1, 2026 | Award | +100,000 | – | – | 963,549 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Mar 10, 2026 | Tax withholding | −5,021 | – | – | 7,004,550 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Mar 10, 2026 | Tax withholding | −1,675 | – | – | 794,936 |
| Sean F. Scanlan Chief Innovation Officer | Mar 10, 2026 | Tax withholding | −1,396 | – | – | 704,677 |
| Mark Hair Chief Financial Officer | Mar 10, 2026 | Tax withholding | −3,695 | – | – | 863,549 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Mar 8, 2026 | Tax withholding | −2,062 | – | – | 7,009,571 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Mar 8, 2026 | Tax withholding | −175 | – | – | 796,611 |
| Sean F. Scanlan Chief Innovation Officer | Mar 8, 2026 | Tax withholding | −401 | – | – | 706,073 |
| Mark Hair Chief Financial Officer | Mar 8, 2026 | Tax withholding | −964 | – | – | 867,244 |
| Sean F. Scanlan Chief Innovation Officer | Feb 10, 2026 | Option exercise | +16,875 | $1.05 | $17.72K | 706,474 |
| Mark Hair Chief Financial Officer | Jan 22, 2026 | Tax withholding | −17,037 | – | – | 493,208 |
| Mark Hair Chief Financial Officer | Jan 22, 2026 | Award | +375,000 | – | – | 868,208 |
| Sean F. Scanlan Chief Innovation Officer | Jan 22, 2026 | Award | +262,500 | – | – | 689,599 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jan 22, 2026 | Award | +250,000 | – | – | 7,011,633 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jan 22, 2026 | Tax withholding | −14,254 | – | – | 6,761,633 |
| Gaetano Guglielmino Chief Commercial Officer | Jan 22, 2026 | Award | +150,000 | – | – | 490,901 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Jan 22, 2026 | Award | +262,500 | – | – | 796,786 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Jan 22, 2026 | Tax withholding | −9,451 | – | – | 534,286 |
| Sean F. Scanlan Chief Innovation Officer | Jan 21, 2026 | Option exercise | +53,500 | $0.72 | $38.52K | 427,099 |
| Mark Hair Chief Financial Officer | Jan 10, 2026 | Tax withholding | −8,719 | – | – | 510,245 |
| John T. Treace Chief Executive Officer, Director, 10% owner | Jan 10, 2026 | Tax withholding | −13,219 | – | – | 6,775,887 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Jan 10, 2026 | Tax withholding | −4,544 | – | – | 543,737 |
| Gaetano Guglielmino Chief Commercial Officer | Dec 1, 2025 | Tax withholding | −20,090 | – | – | 342,910 |
| Gaetano Guglielmino Chief Commercial Officer | Dec 1, 2025 | Tax withholding | −2,009 | – | – | 340,901 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Oct 25, 2025 | Tax withholding | −984 | – | – | 548,281 |
| Sean F. Scanlan Chief Innovation Officer | Oct 24, 2025 | Tax withholding | −208 | – | – | 373,599 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Oct 2, 2025 | Tax withholding | −650 | – | – | 549,265 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Sep 30, 2025 | Tax withholding | −16,234 | – | – | 549,915 |
| Sean F. Scanlan Chief Innovation Officer | Aug 9, 2025 | Tax withholding | −9,814 | – | – | 373,807 |
| Aaron Berutti SVP, Sales | Aug 9, 2025 | Tax withholding | −4,907 | – | – | 205,092 |
| Scot Michael Elder Chief Legl & Comp Off, CorpSec | Aug 9, 2025 | Tax withholding | −10,515 | – | – | 566,149 |
| Mark Hair Chief Financial Officer | Aug 9, 2025 | Tax withholding | −22,212 | – | – | 518,964 |
| Sean F. Scanlan Chief Innovation Officer | Jul 18, 2025 | Option exercise | +33,437 | $0.72 | $24.07K | 383,621 |
| Lawrence W. Hamilton Director | May 20, 2025 | Award | +23,917 | – | – | 44,056 |
| Richard W. Mott Director | May 20, 2025 | Award | +23,917 | – | – | 1,096,861 |
| Lance A. Berry Director | May 20, 2025 | Award | +23,917 | – | – | 44,593 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Scanlan Sean Officer | Mar 17, 2025 | 50,000 | $397.50K | Mar 17, 2025 | Exercise of Stock Options |
| Thomas E. Timbie Director | Jun 14, 2023 | 24,266 | $618.72K | Jun 14, 2023 | STOCK OPTION EXERCISE |
| Barry Bays F. Other: Former Board Member | Jun 5, 2023 | 1,042,318 | $27.63M | Jun 5, 2023 | Acquired from issuer in private transaction |
| Barry Bays F. Other: Former Board Member | Jun 2, 2023 | 47,923 | $1.27M | Jun 2, 2023 | Acquired from issuer in private transaction |
| James T. Treace Director | May 1, 2023 | 10,000 | $252.02K | May 1, 2023 | Private placement |
| Barry Bays F. Other: Board Member | Apr 26, 2023 | 40,000 | $1.02M | Apr 26, 2023 | Acquired from issuer in private transaction |
| Barry Bays Revocable Trust U/A 11/11/14 F. Board Member | Apr 11, 2023 | 100,000 | $2.63M | Apr 11, 2023 | Acquired from issuer in private transaction |